A Phase III, Multicenter, randomized, visual,assessor-masked, active-comparator study of the efficacy,safety, and pharmacokinetics of the port delivery system with Ranibizumab in patients with neovascularage-related macular degeneration.

Project: Research project

Project Details

Description

A Phase III, Multicenter, randomized, visual,assessor-masked, active-comparator study of the efficacy, safety, and pharmacokinetics of the port delivery system with Ranibizumab in patients with neovascular age-related macular degeneration.
StatusFinished
Effective start/end date10/31/18 → 12/31/19

Funding

  • GENENTECH, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint